Principal; Independent Consultant
CurrentCurrent board positions:Vital Trace : Vitaltrace.com.auRH Capital Board: RHCAPITAL.vc Ross University Board of Trustees: Adtalem.com (parent company)Intellihealth Inc. Advisory Board: Intellihealth.com
Please complete the CAPTCHA to continue
A concise factual answer block for searchers comparing this professional profile.
Amy Pollack is listed as Principal; Independent Consultant at Atlantis Associates, INC, based in New York, United States. AeroLeads shows a matched LinkedIn profile for Amy Pollack.
Amy Pollack previously worked as Senior Director at Bill & Melinda Gates Foundation and Director at Bill And Melinda Gates Foundation. Amy Pollack holds Residency In Obstetrics And Gynecology from University Of Washington - School Of Medicine.
I have committed my career to improving lives through increased access to life-saving interventions in health. As a double board certified Obstetrician /Gynecologist /Preventive Medicine professional working domestically and globally, my focus is on women and children. I develop and execute data-driven strategies that introduce innovation into service-delivery models. I evaluate and implement disruptive technologies for a changed standard of care. I do this work in early-stage medtech in both the for-profit and non-profit sectors. I take pride in building highly effective teams. As an executive leader I have a special interest in coaching women, empowering them to use their voice and skills with confidence and take on stretch positions for growth.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
New York, New York, United States
Current board positions:Vital Trace : Vitaltrace.com.auRH Capital Board: RHCAPITAL.vc Ross University Board of Trustees: Adtalem.com (parent company)Intellihealth Inc. Advisory Board: Intellihealth.com
Seattle, Washington, United States
- Managing ~80 employees, strategically guided $750 million in annual investments in new technologies and service delivery models in low and middle-income countries.- Oversaw annual investment budget increase from $170 million to $750 million during tenure.- Built a commercialization strategy for innovation introduction to address dual markets (private/public sectors; middle-income/low-income countries). - Created first strategic collaborative structure between upstream R&D and the Maternal, Newborn and Child Health/Family Planning/Nutrition teams. - Hired new director-level leaders, providing year-long executive coaching to facilitate onboarding and ensure strategic alignment. - Led negotiations with big pharma to secure market supply of a novel contraceptive technology.- Led collaborative work initiatives with Global Finance Facility, World Bank, USAID, and WHO using data-based evidence to influence global investment, policy, and practice.
Seattle/New York City
- Led strategy and investiment portfolio for the Maternal Newborn Child Health program strategy team in the Global Development Division. Strategic focus geographies in Africa and South Asia. - Built strong collaboration between upstream R&D aligning pre-market trial endpoints with downstream postmarket implementaion reseach to inform scaling of disruptive technologies and new service delivery models. - External collaborators included multilaterals, bilaterals, and governments. - Focus populations include public sector and women and infants in underserved areas where maternal and infant mortality and morbidity is highest globally.
Minniapolis; New York (Remote)
Established Corporate Safety Office, setting central corporate policy and strategy of Medical Safety across Medtronic’s ($30 billion) 4 major global business groups. Managed a core team of 25 and decentralized matrix team of 65. - Directly managed escalation and resolution of device related global safety events.Integrated and standardized a new model of medical safety operations for clinical and post market surveillance tested for success. VP, Chief Medical Officer, Early Technologies Business (2014 – 2017)VP, Chief Safety Officer, Minimally Invasive Technology Group (legacy Covidien) (2014 – 2017)- Led Medical Affairs operations and strategy for the Global Early Technology Business: innovative and - disruptive diagnostic and therapeutic interventions (pulmonary and GI Pillcam Endoscopy), product development, clinical development pathway pre-and post-market, business development (focus on due diligence), market introduction (professional societies and training). Provided representation to FDA, EMEA, TGA, PMD.- Built the first Covidien safety office to provide centrally managed clinical trial, post market safety oversight, and case resolution. Trained and managed a core team of 25 to provide Medical Safety oversight for Covidien ($13 billion business) and expanded this model at Medtronic post-acquisition.
New Haven Ct
Covidien acquired by Medtronic in 2014Vice President Global Medical Affairs, Surgical Solutions Business Group for Developed and Emerging Markets, (2014 – 2015)- Led operations and strategy leadership of Global Surgical Business medical affairs.Vice President Global Medical Affairs; CMO, Surgical Solutions Business Group | Developed and Emerging Markets (2012 – 2014)- Oversaw Medical Affairs for all combined businesses in Japan, Australia, and China.Vice President, Global Medical Affairs, STI/EMID/Energy (2011 -2012)- Oversaw all Medical Affairs across 3 business groups (140 employees) for US, Japan, Australia, New Zealand, and Canada.Global Medical Director, Soft Tissue Implants, Lyon, France (2010- 2011) - As a surgeon, provided clinical and strategic inputs to the pre-clinical and clinical development pathway (clinical research, product development, post-market vigilance, healthcare economics, regulatory, and multinational medical education) for a synthetic and biologic mesh product innovation for hernia. - Led the corporate response to FDA ban of transvaginal pelvic mesh use.
Boston, Massachusetts, United States
Commons Capital LP (venture capital impact fund with a double bottom line) 2008 - 2010Consultant, Subject Matter Expert, Clinical AdvisorParticipated in model development; seed fund raising;due diligence.
New York, New York, United States
Rockefeller Foundation, Population Council, Wellcome Trust, Packard Foundation
Newark, California, United States
Late-stage medical device company/ female urology Board Member, Consultant, Subject Matter Expert Regulatory, reimbursement, and payer meeting company representative.Led medical device training.
Redwood City, California, United States
Hologic Corp. / Cytec Corp. / Adiana Inc., Redwood City, CA Adiana was acquired by Cytec in 2007; Cytec was subsequently acquired by Hologic.Medical Consultant, Hologic (2008-2009) - Built team of experts needed for PMA submission and stayed through PMA approval and design work for FDA required post-market studies.- Medical Consultant, Cytec (2007 – 2008)Retained post acquisition to complete regulatory planning and conclude pivotal trial Chief Medical Officer, Adiana Inc. (2006 – 2007)- Led final stages of pivotal clinical trial, negotiations with the FDA, outcome analytics. Partnered with the CEO through the company’s acquisition.
New York, New York, United States
International health care organization | 400 employees | 30 countriesChief Executive Officer (1996 – 2006)- Managed a non-profit budget ($40 million) for growth.- Served an international Board of Directors- Led international women’s health policy/regulatory initiatives for HPV vaccine, obstetric fistula, and emerging markettechnologies.- As technical expert, negotiated with and served US government, multilaterals (FDA, UN, WHO, Global Fund), and countrygovernments (Africa, Asia, Latin America) on emerging market technologies. • Increased budget by 40% while reducing governmental funding dependence from 95% to 45%.• Received UNFPA Population Award.Chief Medical Officer (1991 – 1996)- Rebuilt medical staff for expansion, operating on three continents.- Led clinical trials for regulated products in Africa, Asia, and Latin America.
Residency- Obstetrics and Gynecology Residency- Preventive Medicine Masters in Public Health
Quick answers generated from the profile data available on this page.
Amy Pollack works for Atlantis Associates, INC.
Amy Pollack is listed as Principal; Independent Consultant at Atlantis Associates, INC.
Amy Pollack is based in New York, United States while working with Atlantis Associates, INC.
Amy Pollack has worked for Atlantis Associates, Inc, Bill & Melinda Gates Foundation, Bill And Melinda Gates Foundation, Medtronic, and Covidien Lp.
You can use AeroLeads to view verified contact signals for Amy Pollack at Atlantis Associates, INC, including work email, phone, and LinkedIn data when available.
Amy Pollack holds Residency In Obstetrics And Gynecology from University Of Washington - School Of Medicine.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contactsCheck these profiles if this is not the Amy Pollack you were looking for.